Formaini Nathan, Jacob Paul, Willis Leisel, Kean John R
Nationwide Children's Hospital, Columbus, OH, USA.
J Pediatr Orthop. 2012 Oct-Nov;32(7):737-40. doi: 10.1097/BPO.0b013e318269543b.
To evaluate the rate of infection after minimally invasive procedures on a consecutive series of pediatric orthopaedic patients. We hypothesized that the use of preoperative antibiotics for minimally invasive pediatric orthopaedic procedures does not significantly reduce the incidence of surgical site infection requiring surgical debridement within 30 days of the primary procedure.
We retrospectively reviewed 2330 patients having undergone minimally invasive orthopaedic procedures at our institution between March 2008 and November 2010. Knee arthroscopy, closed reduction with percutaneous fixation, soft tissue releases, excision of bony or soft-tissue masses, and removal of hardware constituted the vast majority of included procedures. Two groups, based on whether prophylactic antibiotics were administered before surgery, were created and the incidence of a repeat procedure required for deep infection was recorded. Statistical analysis was performed to determine significance, if any, between the 2 groups.
Chart review of the 2330 patients identified 1087 as having received preoperative antibiotics, whereas the remaining 1243 patients did not receive antibiotics before surgery. Only 1 patient out of the 1243 cases in which antibiotics were not given required additional surgery within 30 days of the primary procedure due to a complicated surgical site infection (an incidence of 0.0008%). No patients in the antibiotic group developed a postoperative infection within 30 days requiring a return to the operating room for management. Our data revealed no significant increase in the incidence of complicated infection requiring additional procedures when antibiotics were not administered before surgery.
Though prophylactic antibiotics have been shown to confer numerous benefits for patients undergoing relatively major operations, their use in cases of minimally invasive and/or percutaneous orthopaedic surgery is not well defined. Our data suggest that the use of prophylactic antibiotics may not be indicated for many less invasive procedures when performed in a low-risk pediatric population. Future studies are warranted to help establish evidence-based guidelines regarding the routine use of prophylactic antibiotics in this specific population, hopefully resulting in improved cost-effectiveness and safety while slowing the emergence of new drug-resistant organisms.
Level III, retrospective comparative.
评估一系列连续的小儿骨科患者接受微创手术后的感染率。我们假设,对于小儿骨科微创手术,术前使用抗生素并不能显著降低初次手术后30天内需要手术清创的手术部位感染发生率。
我们回顾性分析了2008年3月至2010年11月间在我院接受微创手术的2330例患者。纳入的手术绝大多数包括膝关节镜检查、经皮固定闭合复位、软组织松解、骨或软组织肿物切除以及内固定取出。根据术前是否使用预防性抗生素将患者分为两组,并记录深部感染所需再次手术的发生率。进行统计分析以确定两组之间是否存在显著差异。
对2330例患者的病历审查发现,1087例患者接受了术前抗生素治疗,而其余1243例患者术前未接受抗生素治疗。在未使用抗生素的1243例病例中,只有1例因手术部位感染复杂在初次手术后30天内需要再次手术(发生率为0.0008%)。抗生素组中没有患者在术后30天内发生需要返回手术室处理的感染。我们的数据显示,术前未使用抗生素时,需要额外手术的复杂感染发生率没有显著增加。
尽管预防性抗生素已被证明对接受相对大型手术的患者有诸多益处,但其在微创和/或经皮骨科手术中的应用尚无明确界定。我们的数据表明,在低风险小儿人群中进行许多侵入性较小的手术时,可能无需使用预防性抗生素。有必要进行进一步研究,以帮助制定关于该特定人群常规使用预防性抗生素的循证指南,有望提高成本效益和安全性,同时减缓新耐药菌的出现。
三级,回顾性比较研究。